Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Moderna Therapeutics, the Cambridge, Mass.-based messenger RNA (mRNA) therapeutics start-up, has opened a $110 million, 18,600-m2 production facility. The plant will house over 200 employees and make mRNA molecules for the company’s clinical programs, including its ischemic heart disease partnership with AstraZeneca. The plant will also make mRNA for Moderna’s vaccine programs, including vaccines for infectious diseases, mosquito-borne diseases, and cancer.
This article has been sent to the following recipient: